Content
WeWork, Office Space Worth More Than $47 Billion?
Article By:
David P. Sims, CPA
Read
Wednesday, August 21, 2019 3:30 AM EDT
WeWork allows start-ups and companies to rent office space.
In this article: WE
Week In Review: Chipscreen Gains 367% Following $148 Million Shanghai STAR IPO
Article By:
ChinaBio® Today
Read
Saturday, August 17, 2019 4:06 PM EDT
China's Chipscreen Bio traded 367% higher following its $148 million IPO on the Shanghai STAR exchange, raising its market cap to $4.2 billion.
Crude Oil Forecast: Lack Of Demand Vs ARAMCO IPO
Article By:
Mark Holden
Read
Sunday, August 11, 2019 10:37 AM EDT
Oil prices increased more than 3% with the news that Saudi Arabia is working to have its state oil giant Saudi Aramco list on a stock market as early as at the beginning of 2020, the WJI reported on Friday, quoting people close to the talks.
Week In Review: Nanjing King-Friend Invests $95 Million In US Partner, Meitheal Pharma
Article By:
ChinaBio® Today
Read
Saturday, August 10, 2019 6:05 PM EDT
Nanjing King-Friend Bio invested $95 million in Meitheal Pharma of Chicago, a generic injectables company, raising its holdings to a majority stake.
In this article: GILD
Week In Review: United Healthcare, A China Hospital Chain, Acquired For $1.4 Billion
Article By:
ChinaBio® Today
Read
Saturday, August 3, 2019 5:22 PM EDT
This week in deals and financing, United Family Healthcare, a China hospital chain, will be acquired by New Frontier Corp from TPG and Fosun Pharma at an expected value of $1.44 billion.
Week In Review: Wild Trading On Opening Day At Shanghai STAR Exchange; Shenzhen Chipscreen To IPO On STAR Next Week
Article By:
ChinaBio® Today
Read
Saturday, July 27, 2019 7:24 PM EDT
The first 25 young China high-tech companies to IPO on Shanghai's STAR Exchange soared an average of 140% when they began trading; Shenzhen ChipScreen is expected to IPO on STAR next week.
AB InBev’s Deal Machine Goes Into Smart Reverse
Article By:
Lipper Alpha Insight
Read
Monday, July 22, 2019 12:00 PM EDT
Anheuser-Busch InBev’s deal machine is going into a smart reverse.
In this article: BUD
The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
Week In Review: Three China Biopharmas Announce Plans For Shanghai/Hong Kong IPOs
Article By:
ChinaBio® Today
Read
Saturday, July 20, 2019 5:27 PM EDT
HitGen of Chengdu, a small molecule discovery CRO, was approved for a $97 million IPO on Shanghai's new STAR Exchange and Shenzhen Chipscreen Biosciences, a profitable company, will IPO on Shanghai's STAR Board.
Week In Review: Jibeier Pharma Files To Raise $100 Million In IPO On New Shanghai STAR Board
Article By:
ChinaBio® Today
Read
Sunday, July 7, 2019 12:07 AM EDT
Jibeier Pharma, expects to raise $100 million in the offering. The company, plans to use the funds to build a new drug manufacturing facility and R&D center, and to support its R&D of new drugs along with clinical trials.
